Changes of n-hexane metabolites in urine of rats exposed to various concentrations of n-hexane and to its mixture with toluene or MEK.
M Iwata, Y Takeuchi, N Hisanaga, Y Ono
Index: Int. Arch. Occup. Environ. Health 53(1) , 1-8, (1983)
Full Text: HTML
Abstract
It is well known that n-hexane produces peripheral neuropathy, and 2,5-hexanedione, one of the metabolites of n-hexane, is thought to be the main causative agent. Recently, the metabolites of n-hexane in urine have been measured by gas chromatography, and 2,5-hexanedione was proved to be useful for the biological monitoring of n-hexane exposure. In the present experiment, we intended to clarify the change of n-hexane metabolites in the urine of rats exposed to various concentrations of n-hexane and to its mixture with toluene of MEK. In the first experiment, five separate groups of five rats each were exposed to 100, 500, 1000, or 3000 ppm of n-hexane, or fresh air respectively in an exposure chamber for 8 h a day. Urinary samples were gathered during exposure, 16, 24, and 40 h after exposure. Half of each sample was analyzed by gas chromatography after hydrolysis with acid and enzymes, and the other half was analyzed without hydrolysis. 2,5-Dimethylfuran, MBK, 2-hexanol, 2,5-hexanedione, and gamma-valerolactone could be identified as n-hexane metabolites in the urine. The main metabolites were 2-hexanol and 2,5-hexanedione. 2-Hexanol was mostly excreted during exposure, while most of the 2,5-hexanedione was excreted after the end of exposure. The amount of metabolites in the urine correlatively increased with the concentration of n-hexane from 100 to 1000 ppm, but the amount of metabolites scarcely increased when the concentration of n-hexane increased from 1000 to 3000 ppm.(ABSTRACT TRUNCATED AT 250 WORDS)
Related Compounds
Related Articles:
2014-10-01
[Arch. Microbiol. 196(10) , 681-95, (2014)]
Bioavailability and catabolism of green tea flavan-3-ols in humans
2010-01-01
[Nutrition 26(11-12) , 1110-6, (2010)]
Nonenzymatic sugar production from biomass using biomass-derived γ-valerolactone.
2014-01-17
[Science 343(6168) , 277-80, (2014)]
2011-12-16
[ChemSusChem 4(12) , 1838-43, (2011)]
2009-12-17
[Org. Lett. 11(24) , 5642-5, (2009)]